poisar

Stocks · News reference

The9 Says Investee Nanyang Biologics Received SEC Notice Of Effectiveness For Form F-4 Ahead Of Nasdaq Listing At $1.5B Pre-Transaction Valuation; Expects To Own 15% To 16% Of Combined Company

BenzingaAug 11, 2026, 12:32 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 11, 2026, 12:32 PM
Checked
Aug 11, 2026, 12:32 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading